Skip to main content

Table 2 Participants’ characteristics

From: Walking-adaptability therapy after stroke: results of a randomized controlled trial

 

C-Mill therapy

(n = 16)

FALLS program (n = 17)

p value

Gender (female/male)

9/7

5/12

0.13c

Age at intake (years)

52 ± 13

59 ± 10

0.13a

Height (cm)

171 ± 10

175 ± 7

0.40a

Body mass (kg)

76 ± 13

80 ± 14

0.18a

Time since stroke at intake (months, median)

46 (6–372)

20 (13–110)

0.05c

Side of lesion (left/right)

9/7

8/9

0.66c

Functional Ambulation Category (FAC) at intake (1–5, median)

5 (4–5)

5 (4–5)

0.99c

Berg Balance Scale (BBS) (0–56, median)

55 (39–56)

53 (46–56)

0.58c

Mini-Mental State Examination MMSE (0–30, median)

29 (26–30)

28 (22–30)

0.63c

Assistive device (none/(k)evo/walking cane)

6/4/6

10/3/4

0.22c

Level of activity (1–5 days a week at least 30 min moderate active)

1 (0–5)

2 (0–5)

0.31c

Falls past year (n, %)

8, 50%

13, 76%

0.12b

Fear of falling (1 (no fear of falling)–10 (extreme fear of falling))

5 (1–9)

3 (1–10)

0.31c

Living situation (independently/independently with help)

3/13

6/11

0.42c

Comorbidities (n, %)

9, 57%

10, 59%

0.58b

  1. p values were obtained using aIndependent t-test, bFisher’s exact test, or cMann-Whitney U test. Tendencies towards significant differences are presented in italic (0.05 < p < 0.075)